News for Nano-X Imaging Ltd. (NNOX)

Nanox (NNOX) secures FDA 510(k) clearance, paving the way for advanced medical imaging access. Analysts project significant upside potential, with the a

Quick Summary: Nano-X Imaging (NNOX) has gained significant momentum with U.S. FDA clearance for its Nanox.ARC X device. Analysts set a promising target

Key Takeaways: Nano-X Imaging's revenue and EPS miss analysts' expectations, yet the company projects robust annual revenue growth. Analyst price targets

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicatio

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paran...

Operator: Good day and thank you for standing by. Welcome to the Nano-X Fourth Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ETCompany ParticipantsMike Cavanaugh - Investor RelationsErez...

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Nano-X Imaging Ltd. (NASDAQ:NNOX) stands against other top AI news updates investors should not miss. The global AI industry is growing at a rapid pace but a looming […]

Nano-X Imaging (NNOX) is set to report its fourth-quarter financial results on March 31 before the market opens. Analysts project an earnings per share (EPS) of

PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", NNOX), an innovative medical imaging technology compan

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conv

**media[550067]**

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S.New cli

SoundHound AI stock plummeted 23.1% to $11.72 after Nvidia (NVDA) sold its entire stake in the AI-powered voice technology company. Nvidia previously held 1.7 million shares worth over $8 million, but its sudden exit led to a market sell-off, raising concerns about SoundHound AI's future. Nvidias move aligns with its investment shift toward self-driving and AI cloud firms like WeRide Inc. and Nebius Group N.V..

Feb 14 - A regulatory filling reveals that Nvidia (NVDA, Financial) cut its stake in British chipmaker Arm Holdings (ARM, Financial) by more than 44%, with 1.1

(Reuters) - Nvidia reduced its stake in British chip firm Arm Holdings by about 44% and exited its holdings in Serve Robotics and SoundHound AI in the fourth quarter, a regulatory filing showed on Friday.

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...

U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Shares of Ulta Beauty, Inc. ULTA rose sharply during Friday’s sessi...

**media[484124]**